Pepcid and Ultravate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Ultravate (halobetasol propionate). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Ultravate. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Ultravate?

Ultravate has active ingredients of halobetasol propionate. eHealthMe is studying from 604 Ultravate users. Check the latest studies of Ultravate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

20 people who take Pepcid and Ultravate together, and have interactions are studied.

What are the common drug interactions of Pepcid and Ultravate, by gender? *:

female:

Fatigue (feeling of tiredness)
Abdominal distension
Malaise (a feeling of general discomfort or uneasiness)
Pulmonary mass
Sinusitis (inflammation of sinus)
Staphylococcal infection (an infection with staphylococcus bacteria)
Back pain
Fall
Scar
Arrhythmia (irregular heartbeat)

male:

n/a

What are the common drug interactions of Pepcid and Ultravate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal distension
Abdominal pain
Device dislocation
Dysmenorrhoea (painful menstruation)
Fatigue (feeling of tiredness)
Lymphocyte count decreased
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Migraine (headache)
Uterine haemorrhage (uterine bleeding)
Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depression
Hypertension (high blood pressure)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Pain

60+:

Infusion site pruritus (severe itching at infusion site)
Malaise (a feeling of general discomfort or uneasiness)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depression
Drug ineffective
Hydronephrosis (water inside the kidney)
Hypertension (high blood pressure)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nephrolithiasis (calculi in the kidneys)
Pain

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 35.00%
Depression: 5 people, 25.00%
Pain: 3 people, 15.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.00%
Migraine Without Aura (headache without neurological problems): 3 people, 15.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 15.00%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 10.00%
Menopause (end of monthly cycles in women): 2 people, 10.00%
High Blood Pressure: 2 people, 10.00%
High Blood Cholesterol: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Ultravate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously